While reporting financial results for the fourth quarter on Friday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for the full-year 2025.
For fiscal 2025, the company now projects adjusted earnings in a range of $4.90 to $5.00 per share on total revenues between $2.80 billion and $2.85 billion.
On average, analysts polled expect the company to report earnings of $5.00 per share on revenues of $2.86 billion for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback: editorial@rttnews.com